These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 16987545

  • 1. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
    Erb S, Kayyali H, Romero K.
    Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
    [Abstract] [Full Text] [Related]

  • 2. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF.
    Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
    [Abstract] [Full Text] [Related]

  • 3. Cocaine pre-exposure enhances CRF-induced expression of c-fos mRNA in the central nucleus of the amygdala: an effect that parallels the effects of cocaine pre-exposure on CRF-induced locomotor activity.
    Erb S, Funk D, Lê AD.
    Neurosci Lett; 2005 Aug 05; 383(3):209-14. PubMed ID: 15955413
    [Abstract] [Full Text] [Related]

  • 4. A role for corticotropin-releasing factor in the long-term expression of behavioral sensitization to cocaine.
    Erb S, Brown ZJ.
    Behav Brain Res; 2006 Sep 25; 172(2):360-4. PubMed ID: 16822557
    [Abstract] [Full Text] [Related]

  • 5. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
    Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF.
    Alcohol Clin Exp Res; 2002 Oct 25; 26(10):1494-501. PubMed ID: 12394282
    [Abstract] [Full Text] [Related]

  • 6. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex.
    Bijlsma EY, van Leeuwen ML, Westphal KG, Olivier B, Groenink L.
    Neuroscience; 2011 Jan 26; 173():82-92. PubMed ID: 21093544
    [Abstract] [Full Text] [Related]

  • 7. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
    Pollandt S, Liu J, Orozco-Cabal L, Grigoriadis DE, Vale WW, Gallagher JP, Shinnick-Gallagher P.
    Eur J Neurosci; 2006 Sep 26; 24(6):1733-43. PubMed ID: 17004937
    [Abstract] [Full Text] [Related]

  • 8. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
    Sherrin T, Todorovic C, Zeyda T, Tan CH, Wong PT, Zhu YZ, Spiess J.
    Mol Psychiatry; 2009 Mar 26; 14(3):291-307. PubMed ID: 18195718
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Corticotropin-releasing factor (CRF)-induced behaviors are modulated by intravenous administration of teneurin C-terminal associated peptide-1 (TCAP-1).
    Al Chawaf A, Xu K, Tan L, Vaccarino FJ, Lovejoy DA, Rotzinger S.
    Peptides; 2007 Jul 26; 28(7):1406-15. PubMed ID: 17644218
    [Abstract] [Full Text] [Related]

  • 14. Repeated intracerebral teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to corticotropin-releasing factor (CRF) in rat models of anxiety.
    Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S.
    Behav Brain Res; 2008 Mar 17; 188(1):195-200. PubMed ID: 18082275
    [Abstract] [Full Text] [Related]

  • 15. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
    Adamec R, Strasser K, Blundell J, Burton P, McKay DW.
    Behav Brain Res; 2006 Feb 28; 167(2):270-86. PubMed ID: 16256211
    [Abstract] [Full Text] [Related]

  • 16. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats.
    Zorrilla EP, Valdez GR, Weiss F.
    Psychopharmacology (Berl); 2001 Dec 28; 158(4):374-81. PubMed ID: 11797058
    [Abstract] [Full Text] [Related]

  • 17. Conditioned increases in anxiogenic-like behavior following exposure to contextual stimuli associated with cocaine are mediated by corticotropin-releasing factor.
    DeVries AC, Pert A.
    Psychopharmacology (Berl); 1998 Jun 28; 137(4):333-40. PubMed ID: 9676892
    [Abstract] [Full Text] [Related]

  • 18. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms.
    Chae Y, Yeom M, Han JH, Park HJ, Hahm DH, Shim I, Lee HS, Lee H.
    Neurosci Lett; 2008 Jan 10; 430(2):98-102. PubMed ID: 18060697
    [Abstract] [Full Text] [Related]

  • 19. Anxiety-like responses in adolescent rats following a 10-11-day withdrawal period from repeated cocaine administration.
    Santucci AC, Rosario A.
    Brain Res Bull; 2010 Mar 16; 81(4-5):441-4. PubMed ID: 19963046
    [Abstract] [Full Text] [Related]

  • 20. Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats.
    Erb S, Funk D, Lê AD.
    Psychopharmacology (Berl); 2003 Dec 16; 170(4):383-9. PubMed ID: 12955298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.